NeurologyLive® Staff
Advertisement
Articles by NeurologyLive® Staff
Here's some of what is coming soon to NeurologyLive® this week.
FDA Supports A-Synuclein Assay for PD Trials, VES001 Meets Primary End Point, Digital Migraine Therapeutic CT-132 Performs
Published: | Updated:
Neurology News Network. for the week ending September 14, 2024. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 13, 2024.
Here's some of what is coming soon to NeurologyLive® this week.
Tolebrutinib Shows Promise in Non-Relapsing Secondary Progressive MS, Fenebrutinib Suppresses Relapses in New Data, FDA Accepts Resubmitted NDA for AXS-07
Published: | Updated:
Neurology News Network. for the week ending September 7, 2024. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 6, 2024.
Here's some of what is coming soon to NeurologyLive® this week.
AMX0035's Potential in Tauopathies, Alkermes Initiates Phase 2 Study of ALKS 2680, EryDex Falls Short in Phase 3 ATTeST Trial
Published: | Updated:
Neurology News Network. for the week ending August 31, 2024. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 30, 2024.
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 23, 2024.
Here's some of what is coming soon to NeurologyLive® this week.
Medtronic DBS Approved for Asleep Surgery, BHV-2100 Shows Early Promise, AOC 1044 Continues Dystrophin Production in Latest Update
Published: | Updated:
Neurology News Network. for the week ending August 17, 2024. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 16, 2024.
Here's some of what is coming soon to NeurologyLive® this week.
IND Cleared for Cell Therapy in Progressive MS, FDA Approves IPX203, Migraine Treatment Nerivio Safe in Pediatric Populations
Published: | Updated:
Neurology News Network. for the week ending August 10, 2024. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 9, 2024.
Here's some of what is coming soon to NeurologyLive® this week.
ALPHA-1062 Approved for Alzheimer Disease, GLP-1 Agonist Shows Neuroprotective Effects Against Dementia, Lecanemab 3-Year Data Reported
Published: | Updated:
Neurology News Network. for the week ending August 3, 2024. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 2, 2024.
Sleeping Around the Podcast × NeurologyLive brings you a clinical overview of the use of erenumab, an FDA-approved medication for migraine, and the interactions between CGRP and orexin.
Here's some of what is coming soon to NeurologyLive® this week.
Cerliponase Alfa Approved for All Ages of CLN2 Disease, SAGE-324 Discontinued, ION582 to Advance to Phase 3 in Angelman Syndrome
Published: | Updated:
Neurology News Network. for the week ending July 27, 2024. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 26, 2024.
NeurologyLive joins the CMSC in mourning the loss of founder and CEO,June Halper, MSN, APC-C, MSCN, FAAN.
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 19, 2024.
Here's some of what is coming soon to NeurologyLive® this week.
LX2006 Improves Cardiac Biomarkers of FA, ATH434 Positive Results in MSA, Brivaracetam Effective Regardless of Intellectual Disabilities
Published: | Updated:
Neurology News Network. for the week ending July 20, 2024. [WATCH TIME: 4 minutes]
Advertisement
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
8 Emerging Therapies Shaping the Muscular Dystrophy Treatment Landscape
2
Exploring the Link Between Football Players and ALS: Rory Siegel, DO
3
Exploring the Unmet Needs in CIDP
4
FDA Approves Apitegromab for Spinal Muscular Atrophy
5